1 of 1
EVOFLUx Predicts Cancer
- The EVOFLUx test analyzes DNA methylation changes to predict cancer treatment needs, offering a cost-effective personalized care method.
- Researchers from The Institute of Cancer Research, London, and IDIBAPS in Barcelona developed the test, which shows potential for various blood cancers.
- It indicates that some cancers can remain undetected for over a decade, while others progress rapidly.
- A £3.8 million project at the University of Southampton will train researchers to create Oligonucleotide-based treatments targeting cancer's genetic causes, aiming to improve therapies for lung cancer and chronic inflammation while reducing traditional animal testing.
